Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
A number of treatments for non-alcoholic steatohepatitis (NASH) have shown promise in recent mid-stage trials.
The 2019 Liver Meeting in Boston provided an array of important findings about the treatment and prevention of chronic liver diseases.
Initial 12-week results of a 48-week treatment period showed the drug led to a significant decline in weight and liver enzymes.
The NAFLD/NASH medications’ page includes specific information about each of the experimental dru...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.